Abstract:Background: Single Amino Acid Polymorphisms (SAPs) or nonsynonymous Single Nucleotide Variants (nsSNVs) are the most common genetic variations. They result from missense mutations where a single base pair substitution changes the genetic code in such a way that the triplet of bases (codon) at a given position is coding a different amino acid. Since genetic mutations sometimes cause genetic diseases, it is important to comprehend and foresee which variations are harmful and which ones are neutral (not causing changes in the phenotype). This can be posed as a classification problem. Methods: Computational methods using machine intelligence are gradually replacing repetitive and exceedingly overpriced mutagenic tests. By and large, uneven quality, deficiencies, and irregularities of nsSNVs datasets debase the convenience of artificial intelligence-based methods. Subsequently, strong and more exact approaches are needed to address these problems. In the present work paper, we show a consensus classifier built on the holdout sampler, which appears strong and precise and outflanks all other popular methods. objective: Roughly a half of known disease-related mutations are due to non-synonymous variants [8-9], expressed as amino-acid mutations. Therefore, it is important to unravel the links between nonsynonymous Single Nucleotide Variants and associated diseases to discriminate between pathogenic and neutral substitutions. It has been found that these substitutions could be directly related to pathological effects such as Parkinson’s or Alzheimer’s diseases, or to the involvement in complex diseases, such as cancer development. Results: We produced 100 holdouts to test the structures and diverse classification variables of diverse classifiers during the training phase. The finest performing holdouts were chosen to develop a consensus classifier and tested using a k-fold (1 ≤ k ≤5) cross-validation method. We also examined which protein properties have the biggest impact on the precise prediction of the effects of nsSNVs. Conclusion: Our Consensus Holdout Sampler outflanks other popular algorithms, and gives excellent results, highly accurate with low standard deviation. The advantage of our method emerges from using a tree of holdouts, where diverse LM/AI-based programs are sampled in diverse ways.

Prioritisation of Candidate Single Amino Acid Polymorphisms Using One-Class Learning Machines.

Extraction of Sequence Conservation Features for the Prioritization of Candidate Single Amino Acid Polymorphisms

Prioritization of Candidate Nonsynonymous Single Nucleotide Polymorphisms via Sequence Conservation Features

Sequence-Based Prioritization of Nonsynonymous Single-Nucleotide Polymorphisms for the Study of Disease Mutations

Improved Detection of Rare Genetic Variants for Diseases

Identification Of Sequence Variants In Genetic Disease-Causing Genes Using Targeted Next-Generation Sequencing

Integrating sequence conservation features and a domain-domain interaction network to detect disease-associated nsSNPs

Identification of Disease-Related Nssnps Via the Integration of Protein Sequence Features and Domain-Domain Interaction Data.

Predicting functional impact of single amino acid polymorphisms by integrating sequence and structural features

Comparative Study of Ensemble Learning Approaches in the Identification of Disease Mutations

Supervised Learning-Based Tagsnp Selection for Genome-Wide Disease Classifications

Prioritization of Nonsynonymous Single Nucleotide Variants for Exome Sequencing Studies Via Integrative Learning on Multiple Genomic Data

Assessing concordance among human, in silico predictions and functional assays on genetic variant classification.

Prediction of Deleterious Single Amino Acid Polymorphisms with a Consensus Holdout Sampler

Inferring Non-Synonymous Single-Nucleotide Polymorphisms-Disease Associations Via Integration of Multiple Similarity Networks

Identification of Deleterious Single Amino Acid Polymorphism Using Sequence Information Based on Feature Selection and Parameter Optimization

Explicable prioritization of genetic variants by integration of rule-based and machine learning algorithms for diagnosis of rare Mendelian disorders

Efficient Utilization of Rare Variants for Detection of Disease-Related Genomic Regions

Predicting Mendelian Disease-Causing Non-Synonymous Single Nucleotide Variants in Exome Sequencing Studies

Predicting Pathogenic Single Nucleotide Variants Through a Comprehensive Analysis on Multiple Level Features

Evaluation of an Automated Genome Interpretation Model for Rare Disease Routinely Used in a Clinical Genetic Lab